How Many Patients Will Benefit From a New Therapy for Chronic Systolic Heart Failure, and What Difference Does it Make?

被引：2
|
作者：
Borer, Jeffrey S. [1 ,2 ,3 ,4 ]
机构：
[1] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, Brooklyn, NY 11203 USA
[2] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, Brooklyn, NY 11203 USA
[3] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, New York, NY 10128 USA
[4] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, New York, NY 10128 USA
来源：
JACC-HEART FAILURE | 2015年 / 3卷 / 03期
关键词：
f-channels; heart rate reduction; myocardial function; RATE REDUCTION; OUTCOMES; SHIFT; ASSOCIATION; IVABRADINE; FORCE; CARE;
D O I：
10.1016/j.jchf.2014.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [41] How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy?
    Grimm, W
    Sharkova, J
    Funck, R
    Maisch, B
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (01): : 155 - 157
  • [42] Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay
    Alonso, C
    Ritter, P
    Leclercq, C
    Mabo, P
    Bailleul, C
    Daubert, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09): : 1144 - 1147
  • [43] How many patients admitted for heart failure are eligible for cardiac resynchronization therapy?: Analysis of the Andalusian Heart Failure Registry (RAIC) Study
    Garcia-Pinilla, Jose M.
    Jimenez-Navarro, Manuel F.
    Anguita-Sanchez, Manuel
    Martinez-Martinez, Angel
    Torres-Calvo, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (01): : 38 - 44
  • [44] DOES INOTROPIC THERAPY SHORTEN SURVIVAL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE
    LEE, WH
    PACKER, M
    CIRCULATION, 1985, 72 (04) : 283 - 283
  • [45] Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: Review of trials and practical considerations
    Klein, L
    O'Connor, CM
    Gattis, WA
    Zampino, M
    de Luca, L
    Vitarelli, A
    Fedele, F
    Gheorghiade, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09): : 18F - 40F
  • [46] New data suggest chemotherapy patients benefit from heart failure treatment
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (12): : 1598 - 1598
  • [47] What Doses of β-Blockers are Being Used for Systolic Heart Failure in Patients Without Chronic Obstructive Pulmonary Disease?
    Trump, Tyler
    Robinson, John
    Syed, Qaisar
    Kostelic, Phillip
    Kerr, Kimberly
    Kemper, Suzanne
    Carter, William
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S38 - S38
  • [48] SUSPECTED SARCOMA: WHAT DOES THE RHEUMATOLOGIST NEED TO KNOW? HOW YOU CAN MAKE A DIFFERENCE TO PATIENTS WITH A RARE CANCER
    Gregory, Jonathan
    RHEUMATOLOGY, 2017, 56 : 14 - 15
  • [49] Are statins of clinical benefit in patients with established systolic chronic heart failure? A retrospective analysis of 5010 patients enrolled in Val-HeFT
    Krum, H
    Carretta, E
    Latini, R
    Maggioni, A
    Masson, S
    CIRCULATION, 2004, 110 (17) : 680 - 680
  • [50] Utilisation of Telehome Monitoring in Patients over the Age of 75 with Complex Heart Failure; Does Age Make Any Difference?
    Lemay, Genevieve
    Azad, Nahid
    Struthers, Christine
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S91 - S91
12345